Extension Study to Evaluate the Safety of Long-Term Use of Relacorilant in Patients With Cushing Syndrome
Corcept Therapeutics
Corcept Therapeutics
National Institutes of Health Clinical Center (CC)
University of Michigan
Rutgers, The State University of New Jersey
University Hospital, Toulouse
Johns Hopkins University
University of Colorado, Denver
Duke University
University Hospital, Rouen
Virtual Tribunal Monastery
Novartis
RECORDATI GROUP
Colorado State University
University of Illinois at Chicago
St. Jude Children's Research Hospital
University of North Carolina, Chapel Hill
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
West Michigan Cancer Center
Corcept Therapeutics
West Virginia School of Osteopathic Medicine
Corcept Therapeutics
University of Pittsburgh